Company / Cash per Share
Actinium Pharmaceuticals, Inc. Cash per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.54
FY2025
5-year range
$1.54 / $4.92
FY2021-FY2025
Trend
-41.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has declined for 3 consecutive years, from $4.92 in FY2022 to $1.54 in FY2025.
Based on SEC 10-K filings.
1.54 in FY2025 with a 3-year CAGR of -32.1%.
Declined from $2.99 to $1.54 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -32.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Actinium Pharmaceuticals, Inc.'s cash per share has declined for 3 consecutive years.
- In FY2025, cash per share decreased 41.7% year-over-year.
- Peak cash per share was recorded in FY2022.
- Lowest cash per share in the period was in FY2011.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.54 | -41.7% |
| FY2024 | $2.64 | -11.7% |
| FY2023 | $2.99 | -39.3% |
| FY2022 | $4.92 | +10.8% |
| FY2021 | $4.44 | +768.1% |
| FY2011 | $0.51 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026